Acquisition of Cardiovascular Medications
About This Opportunity
TranslatedThis tender pertains to the procurement of medications specifically for the cardiovascular system. The objective is to ensure the availability of essential drugs that are critical for the treatment and management of cardiovascular diseases. The tender is likely aimed at healthcare institutions, pharmacies, or pharmaceutical suppliers that can provide a range of cardiovascular medications. Key requirements may include compliance with regulatory standards, quality assurance protocols, and the ability to deliver medications within specified timelines. Additionally, bidders may need to demonstrate their capacity to meet the demand for these medications in terms of quantity and variety. The procurement process is expected to follow established public procurement guidelines to ensure transparency and fairness. This initiative is essential for enhancing healthcare services and improving patient outcomes in the cardiovascular sector. Interested parties should prepare to submit their proposals, which will be evaluated based on criteria such as pricing, quality, and delivery capabilities. The location of the procurement is not specified, but it is likely to be within a public health framework, focusing on improving access to necessary medications for patients with cardiovascular conditions.
This is a supplies contract in the health and medical services and trade and industry sectors, with a focus on Pharmaceuticals and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 126.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "Aquisição de Medicamentos do Aparelho Cardiovascular" seeks to procure pharmaceutical products specifically targeting cardiovascular health. This public procurement initiative is taking place in Portugal, a country committed to enhancing its healthcare system and ensuring the availability of essential medications for its population. The contracting authority involved is likely to be a public health institution or a government agency responsible for managing health services in the region.
This tender is expected to attract bids from pharmaceutical companies that can provide a range of cardiovascular medications, which may include but are not limited to antihypertensives, anticoagulants, and lipid-lowering agents. Typical requirements for this type of tender often include compliance with national and European Union regulations on drug safety and efficacy, proof of Good Manufacturing Practices (GMP), and necessary certifications for each product proposed.
Additionally, bidders may be required to demonstrate their capacity for timely delivery, adherence to quality standards, and a proven track record in supplying similar medications to public healthcare facilities. The procurement process is designed to ensure that the selected suppliers can meet the health demands of the population while optimizing costs and enhancing the overall efficiency of the healthcare system.
Overall, this tender reflects Portugal's ongoing efforts to improve healthcare outcomes through the strategic procurement of vital medications, thereby reinforcing its commitment to public health and patient care.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 12, 2026. Last refreshed 6 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Gaia/Espinho, E. P. E.
Unidade Local de Saúde de Gaia/Espinho, E. P. E. has issued 488 procurement notices on BidsFactory, including 0 currently open and 479 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Industry & Manufacturing. All notices are published for Portugal. Notices are distributed via base_gov_pt and TED - Tenders Electronic Daily (EU). Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to NEURAXPHARM PORTUGAL UNIPESSOAL LDA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Gaia/Espinho, E. P. E. in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €126. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.